Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Médecins Sans Frontières (MSF), Eshowe, KwaZulu Natal, South Africa.
Syst Rev. 2020 Dec 12;9(1):292. doi: 10.1186/s13643-020-01524-1.
Despite the increase in the number of people accessing antiretroviral therapy (ART), there is limited data regarding treatment failure and its related factors among HIV-positive individuals enrolled in HIV care in resource-poor settings. This review aimed to identify factors associated with antiretroviral treatment failure among individuals living with HIV on ART in resource-poor settings.
We conducted a comprehensive search on MEDLINE (PubMed), Excerpta Medica Database (EMBASE), Cochrane Central Register of Controlled Trials (CENTRAL), World Health Organization's (WHO's) library database, and Latin American and Caribbean Health Sciences Literature (LILACS). We included observational studies (cohort, case-control, and cross-sectional studies) where adolescents and adults living with HIV were on antiretroviral treatment regardless of the ART regimen. The primary outcomes of interest were immunological, virological, and clinical failure. Some of the secondary outcomes were mm opportunistic infections, WHO clinical stage, and socio-demographic factors. We screened titles, abstracts, and the full texts of relevant articles in duplicate. Disagreements were resolved by consensus. We analyzed the data by doing a meta-analysis to pool the results for each outcome of interest.
Antiretroviral failure was nearly 6 times higher among patients who had poor adherence to treatment as compared to patients with a good treatment adherence (OR = 5.90, 95% CI 3.50, 9.94, moderate strength of evidence). The likelihood of the treatment failure was almost 5 times higher among patients with CD4 < 200 cells/mm compared to those with CD4 ≥ 200 CD4 cells/mm (OR = 4.82, 95% CI 2.44, 9.52, low strength of evidence). This result shows that poor adherence and CD4 count below < 200 cells/mm are significantly associated with treatment failure among HIV-positive patients on ART in a resource-limited setting.
This review highlights that low CD4 counts and poor adherence to ART were associated to ART treatment failure. There is a need for healthcare workers and HIV program implementers to focus on patients who have these characteristics in order to prevent ART treatment failure.
The systematic review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO), registration number: 2019 CRD42019136538.
尽管接受抗逆转录病毒疗法 (ART) 的人数有所增加,但在资源匮乏环境中接受 HIV 护理的 HIV 阳性个体中,关于治疗失败及其相关因素的数据有限。本综述旨在确定资源匮乏环境中接受 ART 的 HIV 阳性个体中与抗逆转录病毒治疗失败相关的因素。
我们对 MEDLINE(PubMed)、Excerpta Medica Database(EMBASE)、Cochrane 中央对照试验注册中心(CENTRAL)、世界卫生组织(WHO)图书馆数据库和拉丁美洲和加勒比健康科学文献(LILACS)进行了全面检索。我们纳入了观察性研究(队列研究、病例对照研究和横断面研究),其中接受抗逆转录病毒治疗的青少年和成年人无论 ART 方案如何。主要结局指标是免疫、病毒学和临床失败。一些次要结局指标是机会性感染、WHO 临床分期和社会人口统计学因素。我们对相关文章的标题、摘要和全文进行了重复筛选。意见分歧通过协商解决。我们通过荟萃分析对每个感兴趣的结局进行数据分析,以汇总结果。
与治疗依从性良好的患者相比,治疗依从性差的患者发生抗逆转录病毒失败的风险高出近 6 倍(OR=5.90,95%CI 3.50,9.94,中等强度证据)。与 CD4 细胞计数≥200 个/mm 的患者相比,CD4 细胞计数<200 个/mm 的患者发生治疗失败的可能性几乎高出 5 倍(OR=4.82,95%CI 2.44,9.52,低强度证据)。这一结果表明,在资源有限的环境中,治疗依从性差和 CD4 计数<200 个/mm 与 HIV 阳性患者接受 ART 治疗失败显著相关。
本综述强调,低 CD4 计数和 ART 治疗依从性差与 ART 治疗失败相关。卫生保健工作者和 HIV 项目实施者需要关注具有这些特征的患者,以预防 ART 治疗失败。
系统评价方案在国际前瞻性系统评价注册库(PROSPERO)中进行了注册,注册号为:2019 CRD42019136538。